Published articles

Published articles 1 records found  Search took 0.01 seconds. 
1.
10 p, 619.3 KB Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial / Rottenkolber, Marietta (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Fischer, Rainald (Pneumologische Praxis Muenchen - Pasing, Munich, Germany) ; Ibáñez, Luisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Fortuny, Joan (Novartis Farmaceutica SA) ; Reynolds, Robert (Pfizer Research & Development, New York, USA) ; Amelio, Justyna (Amgen Ltd, Uxbridge, UK) ; Gerlach, Roman (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Tauscher, Martin (National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany) ; Thürmann, Petra (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany) ; Hasford, Joerg (Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet) ; Schmiedl, Sven (Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany)
After the SMART trial evaluating the safety of salmeterol (long-acting beta-2-agonist (LABA)) in asthma patients, regulatory actions were taken to promote a guideline-adherent prescribing of LABA only to patients receiving inhaled corticosteroids (ICS). [...]
2015 - 10.1186/s12890-015-0051-x
BMC Pulmonary Medicine, Vol. 15 (may 2015)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.